Back to Search Start Over

Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome.

Authors :
Valle-Hita C
Becerra-Tomás N
Díaz-López A
Vázquez-Ruiz Z
Megías I
Corella D
Goday A
Martínez JA
Alonso-Gómez ÁM
Wärnberg J
Vioque J
Romaguera D
López-Miranda J
Estruch R
Tinahones FJ
Lapetra J
Serra-Majem L
Bueno-Cavanillas A
Tur JA
Martín-Sánchez V
Pintó X
Gaforio JJ
Matía-Martín P
Vidal J
Amengual-Galbarte A
Daimiel L
Ros E
García-Arellano A
Barragán R
Fitó M
Peña-Orihuela PJ
Asencio-Aznar A
Gómez-Gracia E
Martinez-Urbistondo D
Morey M
Casas R
Garrido-Garrido EM
Tojal-Sierra L
Damas-Fuentes M
Goñi E
Ortega-Azorín C
Castañer O
Garcia-Rios A
Gisbert-Sellés C
Sayón-Orea C
Schröder H
Salas-Salvadó J
Babio N
Source :
Frontiers in nutrition [Front Nutr] 2022 Sep 30; Vol. 9, pp. 986190. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).
Publication Year :
2022

Abstract

Background: Diets high in acid load may contribute to kidney function impairment. This study aimed to investigate the association between dietary acid load and 1-year changes in glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (UACR).<br />Methods: Older adults with overweight/obesity and metabolic syndrome (mean age 65 ± 5 years, 48% women) from the PREDIMED-Plus study who had available data on eGFR ( n = 5,874) or UACR ( n = 3,639) at baseline and after 1 year of follow-up were included in this prospective analysis. Dietary acid load was estimated as potential renal acid load (PRAL) and net endogenous acid production (NEAP) at baseline from a food frequency questionnaire. Linear and logistic regression models were fitted to evaluate the associations between baseline tertiles of dietary acid load and kidney function outcomes. One year-changes in eGFR and UACR were set as the primary outcomes. We secondarily assessed ≥ 10% eGFR decline or ≥10% UACR increase.<br />Results: After multiple adjustments, individuals in the highest tertile of PRAL or NEAP showed higher one-year changes in eGFR (PRAL, β: -0.64 ml/min/1.73 m <superscript>2</superscript> ; 95% CI: -1.21 to -0.08 and NEAP, β: -0.56 ml/min/1.73 m <superscript>2</superscript> ; 95% CI: -1.13 to 0.01) compared to those in the lowest category. No associations with changes in UACR were found. Participants with higher levels of PRAL and NEAP had significantly higher odds of developing ≥10% eGFR decline (PRAL, OR: 1.28; 95% CI: 1.07-1.54 and NEAP, OR: 1.24; 95% CI: 1.03-1.50) and ≥10 % UACR increase (PRAL, OR: 1.23; 95% CI: 1.04-1.46) compared to individuals with lower dietary acid load.<br />Conclusions: Higher PRAL and NEAP were associated with worse kidney function after 1 year of follow-up as measured by eGFR and UACR markers in an older Spanish population with overweight/obesity and metabolic syndrome.<br />Competing Interests: Author JS-S reported receiving research support from the Instituto de Salud Carlos III (ISCIII), Ministerio de Educación y Ciencia, Departament de Salut Pública de la Generalitat de Catalunya, the European Commission, the California Walnut Commission, Patrimonio Comunal Olivarero, La Morella Nuts, and Borges S.A; receiving consulting fees or travel expenses from California Walnut Commission, Eroski Foundation, Instituto Danone, Abbott Laboratories and Mundifarma, receiving non-financial support from Hojiblanca, Patrimonio Comunal Olivarero, and Almond Board of California; serving on the board of and receiving grant support through his institution from the International Nut and Dried Foundation and the Eroski Foundation; and grants and personal fees from Instituto Danone. Author ER reported receiving grants, personal fees, and non-financial support from the California Walnut Commission during the conduct of the study and grants, personal fees, non-financial support from Alexion; personal fees from Amarin; and non-financial support from the International Nut Council outside the submitted work. Author RE reported receiving grants from Instituto de Salud Carlos III and olive oil for the trial from Fundacion Patrimonio Comunal Olivarero/during the conduct of the study and personal fees from Brewers of Europe, Fundación Cerveza y Salud, Interprofesional del Aceite de Oliva, Instituto Cervantes, Pernaud Richar, Fundación Dieta Mediterránea, Wine and Culinary International Forum; non-financial support from Sociedad Española de Nutrición and Fundación Bosch y Gimpera; and grants from Uriach Laboratories outside the submitted work. Author XP reported receiving grants from ISCIII during the conduct of the study; receiving consulting fees from Sanofi Aventis, Amgen, and Abbott laboratories; receiving lecture personal fees from Esteve, Lacer and Rubio laboratories. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Valle-Hita, Becerra-Tomás, Díaz-López, Vázquez-Ruiz, Megías, Corella, Goday, Martínez, Alonso-Gómez, Wärnberg, Vioque, Romaguera, López-Miranda, Estruch, Tinahones, Lapetra, Serra-Majem, Bueno-Cavanillas, Tur, Martín-Sánchez, Pintó, Gaforio, Matía-Martín, Vidal, Amengual-Galbarte, Daimiel, Ros, García-Arellano, Barragán, Fitó, Peña-Orihuela, Asencio-Aznar, Gómez-Gracia, Martinez-Urbistondo, Morey, Casas, Garrido-Garrido, Tojal-Sierra, Damas-Fuentes, Goñi, Ortega-Azorín, Castañer, Garcia-Rios, Gisbert-Sellés, Sayón-Orea, Schröder, Salas-Salvadó and Babio.)

Details

Language :
English
ISSN :
2296-861X
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in nutrition
Publication Type :
Academic Journal
Accession number :
36245494
Full Text :
https://doi.org/10.3389/fnut.2022.986190